HighTower Advisors LLC Acquires 7,152 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

HighTower Advisors LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 41.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 24,480 shares of the medical instruments supplier’s stock after purchasing an additional 7,152 shares during the period. HighTower Advisors LLC’s holdings in DENTSPLY SIRONA were worth $465,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of XRAY. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB increased its position in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the period. Quarry LP boosted its holdings in shares of DENTSPLY SIRONA by 455.0% in the third quarter. Quarry LP now owns 3,036 shares of the medical instruments supplier’s stock worth $82,000 after buying an additional 2,489 shares during the last quarter. Finally, SRS Capital Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 4,699.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 4,607 shares of the medical instruments supplier’s stock worth $87,000 after purchasing an additional 4,511 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on XRAY. Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Evercore ISI reissued an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, Morgan Stanley cut their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a research note on Tuesday, December 17th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $14.93 on Monday. The firm has a market cap of $2.97 billion, a PE ratio of -7.21, a PEG ratio of 1.80 and a beta of 0.98. The stock has a 50 day moving average of $17.62 and a 200 day moving average of $20.16. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12 month low of $14.78 and a 12 month high of $33.22.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.29%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insider Buying and Selling

In related news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.